NFKB1 and lung carcinoma: This analysis revealed down-regulation of the NF-κB pathway (p-value 2.8 × 10−24), which is consistent with prior studies demonstrating that PF-3758309 suppressed NF-κB signaling in lung cancer cells [8,20].